Detoxified lipopolysaccharide reduces microglial cell killing of prion-infected neurons

NeuroReport

Volumn 15, Issue 18, 2004, Pages 2765-2768

  Bate, Clive ^a   Williams, Alun ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Amyloid ; CD14; Detoxified lipopolysaccharide; Microglial cells; Prion

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CD14 ANTIGEN; CYTOKINE; LIPOPOLYSACCHARIDE; PRION PROTEIN; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL ACTIVATION; CELL CULTURE; CELL ISOLATION; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBER; IN VITRO STUDY; MICROGLIA; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFECTION; LIPOPOLYSACCHARIDES; METABOLIC DETOXICATION, DRUG; MICE; MICROGLIA; NEUROBLASTOMA; NEURONS; PEPTIDE FRAGMENTS; PEPTIDES; PRIONS; TETRAZOLIUM SALTS;

EID: 11244334530     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002; 40:232-239.
2. Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-Ura K and Tateishi J. A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol 1991; 139:589-598.
3. Braak H and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18:351-357.
4. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I and McGeer EG. Microglia in degenerative neurological disease. Glia 1993; 7:84-92.
5. Peyrin JM, Lasmezas CI, Haik S, Tagliavini F, Salmona M, Williams A et al. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 1999; 10:723-729.
6. Del Bo R, Angeretti N, Lucca E, De Simoni MG and Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett 1995; 188:70-74.
7. Bate C, Reid S and Williams A. Killing of prion-damaged neurones by microglia. Neuroreport 2001; 12:2589-2594.
8. Meda L, Cassatella M A, Szendrei G I, Otvos L J, Baron P, Villalba M et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995; 374:647-650.
9. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ and Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-1433.
10. 1-42 damaged neurons by a CD14 dependent process. Neuroreport 2004; 15:1427-1430.
11. Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004; 18:203-205.
12. Ding HF, Nakoneczna I and Hsu HS. Protective immunity induced in mice by detoxified salmonella lipopolysaccharide. J Med Microbiol 1990; 31:95-102.
13. Bonetto V, Massignan T, Chiesa R, Morbin M, Mazzoleni G, Diomede et al. Synthetic miniprion PrP106. J Biol Chem 2002; 277:31327-31334.
14. Becher B, Fedorowicz V and Antel JP. Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res 1996; 45:375-381.
15. Lynn WA, Raetz CR, Qureshi N and Golenbock DT. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists. J Immunol 1991; 147:3072-3079.
16. Bate C, Boshuizen RS, Langeveld JP and Williams A. Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation. Neuroreport 2002; 13:1695-1700.